Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 70Prostatic Neoplasms 50Multiple Myeloma 30Neoplasm Metastasis 28Osteoporosis 16Pain 15Carcinoma, Non-Small-Cell Lung 11Neoplasms 10Lung Neoplasms 8Osteosarcoma 7Neoplasms, Plasma Cell 7Neuroblastoma 6Carcinoma, Renal Cell 6Bone Diseases, Metabolic 6Humoral Hypercalcemia Of Malignancy 5Bone Neoplasms 5Fractures, Bone 4Bone Diseases 4Triple Negative Breast Neoplasms 3Sarcoma, Ewing 3Sarcoma 3Lymphoma 3Kidney Neoplasms 3Uterine Cervical Neoplasms 2Spinal Cord Compression 2Small Cell Lung Carcinoma 2Rhabdomyosarcoma 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Pleural Effusion, Malignant 2Ovarian Neoplasms 2

Interventions

gallium Ga 68 dotatate 1fluorodopa F 18 1Zoledronic Acid 1Standard of Care 1Denosumab 1Cinacalcet 1ARQ 197 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Hypercalcemia × Zoledronic Acid × Clear all
NCT00126386 2011-11-21

Zometa for the Management of Tumor-induced Hypercalcemia and Malignant Bone Pain in the Community

AHS Cancer Control Alberta

Phase NA Completed
11 enrolled

Hypercalcemia, Neoplasms, Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡